Somatostatin receptor‐positive primary breast tumors: Genetic, patient and tumor characteristics
Aart H. Bootsma(Erasmus MC), Ellen C. Zwarthoff(Erasmus MC), Kim Schouten(Erasmus University Rotterdam), Annelies de Klein(Erasmus MC), J.A. Foekens(Rotterdam University of Applied Sciences), Renée van Pel(Erasmus University Rotterdam), J.C. Reubi, Casper H.J. van Eijck(Erasmus MC), Steven W. J. Lamberts(Erasmus MC), Beatrice Waser
Cited by 22
Related Papers
Treatment With the Radiolabeled Somatostatin Analog [ <sup>177</sup> Lu-DOTA <sup>0</sup> ,Tyr <sup>3</sup> ]Octreotate: Toxicity, Efficacy, and Survival
|Journal of Clinical Oncology|2008|1.4k
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial
|Journal of Clinical Oncology|2020|1.1k
Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity
|European Heart Journal|2005|1.1k
FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis
|The Lancet Oncology|2016|914